Living With HIV: Understanding the Patient Experience and Appreciating the Science – Twitter Chat #2

 

 

PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

This program has been developed in collaboration with HealthHIV.

SUPPORTER ACKNOWLEDGEMENT

Supported by an educational grant from Gilead Sciences, Inc.

PROGRAM OVERVIEW

Human immunodeficiency virus (HIV) infection was first documented in the United States in 1981. Since that time, significant strides have been made in the prevention and treatment of the condition. Screening is paramount in identifying early infection and is now a routine component of care, and appropriate management with combination antiretroviral therapy (ART) extends patients’ lives, sometimes for many years. However, therapy is lifelong and complicated by pill burden, cost, adverse effects, drug interactions, and disparities. This Twitter-based discussion elaborates on evidence/guidelines for ART optimization, the need for individualized care when selecting ART therapy for treatment-experienced patients with HIV, and concludes with an overview of emerging antiretrovirals (ARVs).

FACULTY

Monica Gandhi, MD, MPH
Professor of Medicine and Associate Chief
Department of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
University of California San Francisco
Medical Director
Department of Medicine; Ward 86 HIV Clinic
San Francisco General Hospital
San Francisco, California

 

Andrés Henao-Martínez, MD
Associate Professor
Department of Medicine
University of Colorado
Aurora, Colorado

 

Release date: June 13, 2022
Expiration date: September 13, 2022
Estimated time to complete activity: 60 minutes

 

TARGET AUDIENCE

This educational activity has been designed to meet the needs of US-based HIV specialty clinicians and infectious disease physicians involved in managing care for patients who are at risk for or living with HIV.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Select ART regimens that minimize drug-drug interactions and toxicities, support adherence, and consider patient and systemic factors including patient preference
  • Summarize new paradigms and approaches to treating and managing HIV, including potential two-drug ARV combinations
DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of June 13, 2022 through September 13, 2022, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 100%.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this Other activity (Twitter-based discussion) for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of these CME activities:

Monica Gandhi, MD, MPH has no real or apparent conflicts of interest to disclose

Andres Hénao Martínez, MD has no real or apparent conflicts of interest to disclose

The Integrity Continuing Education, Inc. planners and managers have nothing to disclose.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe® Flash® Player 10

  • Adobe® Flash® Player 10 plug-in should be downloaded
  • Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Continue to Pretest